When someone gets sick with meningococcal disease, doctors rush to give antibiotics to their close contacts to prevent more cases. But a growing problem is that the bacteria can become resistant to a key drug, ciprofloxacin. Now, the CDC has issued guidance for health departments, telling them to switch to other preferred antibiotics when an area hits a certain threshold of these resistant cases. This guidance is a map for public health teams, not a report on how effective the new antibiotics are. It doesn't tell us what those specific drugs are, or what happened to people who took them. The advice is purely about responding to the signal of drug resistance. For now, it means health officials have a clearer plan to try and stay ahead of a dangerous infection.
How should doctors protect people exposed to drug-resistant meningitis?
Photo by Meg / Unsplash
What this means for you:
New CDC guidance helps health departments respond to drug-resistant meningitis exposures. More on Meningococcal Disease
Review of ESBL-producing E. coli epidemiology and fluoroquinolone resistance in Mexican community isolates UTIs Are Getting Harder to Treat — Here’s Why
medRxiv · Apr 23, 2026
Meta-analysis of antimicrobial resistance prevalence in Tanzanian hospital pathogens Common Antibiotics Are Failing in Tanzania, New Data Reveals
· Apr 22, 2026
Retrospective cohort study assesses Acinetobacter baumannii prevalence and resistance in ventilator-associated infections. ICU Infection Risk Skyrockets Without Local Drug Data
Frontiers · Apr 16, 2026
Machine learning models predict ciprofloxacin resistance in Shigella isolates from Ontario. New Test Predicts Drug Failure Before It Starts
medRxiv · Apr 16, 2026